Shenyang Sunshine Pharmaceutical Co., LTD. clinical trials

A subsidiary of 3SBio Inc.

The registry lists 40 studies whose lead sponsor is Shenyang Sunshine Pharmaceutical Co., LTD.. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.

Studies

Recruiting first, then most recently updated. Showing 40 of 40. All 3SBio Inc. studies →

• SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung CancerNot yet recruitingNCT07874984Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerRecruitingNCT07757230Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase I Clinical Study to Evaluate the Safety and Efficacy of 3SC009 Monotherapy for Patients With Advanced Solid TumorsNot yet recruitingNCT07815002Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07646626Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult ParticipantsNot yet recruitingNCT07606976Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous InfusionNot yet recruitingNCT07487545Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.Not yet recruitingNCT07445308Phase 1/2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Safety, Tolerability, PK and PD of SSS55 in Healthy SubjectsRecruitingNCT07058779Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase I Study of SPGL008 in Subjects With Advanced Malignant TumorsRecruitingNCT07038005Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant TumorsRecruitingNCT07016490Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） PatientsRecruitingNCT07171606Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal CancersNot yet recruitingNCT07233850Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07022002Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase I Study of SSGJ-612 in Patients With Advanced Solid TumorsRecruitingNCT07032298Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase I Study of HBT-708 for Patients With Advanced Solid TumorsRecruitingNCT06993870Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese SubjectsEnrolling by invitationNCT07057726Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese MalesNot yet recruitingNCT07025915Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• SSGJ-707 in Advanced Non-Small Cell Lung CancerRecruitingNCT06980272Phase 3

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase IIa Trial of Oral SSS17 for Post-Arthroplasty AnemiaNot yet recruitingNCT07007936Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer PainRecruitingNCT07008703Phase 1/2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant TumorsRecruitingNCT06944444Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid MalignanciesNot yet recruitingNCT06854276Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKDCompletedNCT07014631Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy SubjectsCompletedNCT07024888Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)CompletedNCT02947438Phase 3

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal FailureStatus unknownNCT05211167Phase 3

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseStatus unknownNCT05193201Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase 1 Study of SSS17 in Healthy Subjects.Status unknownNCT04893187Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult VolunteersStatus unknownNCT04047394Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating TabletStatus unknownNCT04728984Phase 3

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)TerminatedNCT02522975Phase 4

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function ImpairmentStatus unknownNCT03673215Early Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study of SSS17 in Healthy SubjectsStatus unknownNCT04317833Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With HemodialysisStatus unknownNCT03950687Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)CompletedNCT04089267Phase 4

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.Status unknownNCT03388515Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy SubjectsCompletedNCT02460393Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic CharacteristicsStatus unknownNCT02356419Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLCStatus unknownNCT02344979

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.